In the News… Abbott nabs Bigfoot, low-dose aspirin for T2D, can ChatGPT answer diabetes questions? and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Abbott acquires Bigfoot, a new study looks at low-dose aspirin to prevent type 2, researchers look into whether the AI ChatGPT can answer FAQs about diabetes, Beyond Type Run is back for the…